Immunovant Sciences
Jan 24, 2020
Thyroid eye disease market: New therapies enter the TED market
The newly approved drug teprotumumab can offer hope to adults with thyroid eye disease, a rare and potentially blinding condition. It's the first treatment specifically approved for thyroid eye disease. The drug of Horizon Therapeutics was approved by the U.S. Food and Drug Administration and is set to be marketed ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
